Literature DB >> 8523574

Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene.

R Ray, M S Galinski, B R Heminway, K Meyer, F K Newman, R B Belshe.   

Abstract

We have previously demonstrated that the temperature sensitivity of a human parainfluenza virus type 3 (HPIV-3) candidate vaccine strain (cp45), which is currently under evaluation in humans, is associated with poor transcriptional activity of the virus at the nonpermissive temperature (R. Ray, K. Meyer, F. Newman, and R. B. Belshe, J. Virol. 69:1959-1963, 1995). In this study, the temperature sensitivity of cp45 virus was further investigated by the complementation of a specific gene function. CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins. Only cells expressing the L gene were able to rescue cp45 replication when incubated at the nonpermissive temperature (39.5 degrees C), whereas cells transiently expressing NP or P were incapable of rescuing the virus. The virus titers obtained following complementation of the L protein were 190 to 2,300 PFU/ml of culture medium, compared with the undetectable growth of the cp45 temperature-sensitive mutant at the nonpermissive temperature. Rescued progeny virus still maintained the temperature-sensitive phenotype. Results from this study suggest that the temperature sensitivity of the cp45 candidate vaccine strain is associated primarily with L-protein function and that the defect can be complemented by transient expression of the wild-type protein. This study underscores the importance of the L protein in RNA polymerase activity and its critical role in virus replication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8523574      PMCID: PMC189848     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  A temperature-sensitive mutant of Sendai virus with an altered hemagglutinin-neuraminidase polypeptide: consequences for virus assembly and cytopathology.

Authors:  A Portner; R A Scroggs; P S Marx; D W Kingsbury
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

2.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature-sensitive mutants.

Authors:  S D Thompson; A Portner
Journal:  Virology       Date:  1987-09       Impact factor: 3.616

4.  Expression of the three influenza virus polymerase proteins in a single cell allows growth complementation of viral mutants.

Authors:  M Krystal; R Li; D Lyles; G Pavlakis; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.

Authors:  M J Bouchard; D H Lam; V R Racaniello
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

6.  RNA synthesis by Newcastle disease virus temperature-sensitive mutants in two RNA-negative complementation groups.

Authors:  M E Peeples; L L Rasenas; M A Bratt
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

7.  Virion functions of RNA+ temperature-sensitive mutants of Newcastle disease virus.

Authors:  M E Peeples; M A Bratt
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

8.  Molecular cloning and sequence analysis of the human parainfluenza 3 virus mRNA encoding the P and C proteins.

Authors:  M S Galinski; M A Mink; D M Lambert; S L Wechsler; M W Pons
Journal:  Virology       Date:  1986-11       Impact factor: 3.616

9.  Glycoproteins of human parainfluenza virus type 3: affinity purification, antigenic characterization and reconstitution into lipid vesicles.

Authors:  R Ray; R W Compans
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

10.  Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map.

Authors:  M K Spriggs; P L Collins
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

View more
  7 in total

1.  Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypes.

Authors:  M H Skiadopoulos; A P Durbin; J M Tatem; S L Wu; M Paschalis; T Tao; P L Collins; B R Murphy
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

2.  Biochemical characterizations of two temperature-sensitive and attenuated strains of respiratory syncytial virus subgroup B.

Authors:  J H Broughan; V B Randolph; J M Tatem
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  An infectious clone of human parainfluenza virus type 3.

Authors:  M A Hoffman; A K Banerjee
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections.

Authors:  Xiaoyan Zhan; Karen S Slobod; Sateesh Krishnamurthy; Laura E Luque; Toru Takimoto; Bart Jones; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2008-05-01       Impact factor: 3.641

5.  Temperature Sensitivity: A Potential Method for the Generation of Vaccines against the Avian Coronavirus Infectious Bronchitis Virus.

Authors:  Sarah Keep; Phoebe Stevenson-Leggett; Angela Steyn; Michael S Oade; Isobel Webb; Jamie Stuart; Lonneke Vervelde; Paul Britton; Helena J Maier; Erica Bickerton
Journal:  Viruses       Date:  2020-07-14       Impact factor: 5.818

6.  A Temperature-Sensitive Recombinant of Avian Coronavirus Infectious Bronchitis Virus Provides Complete Protection against Homologous Challenge.

Authors:  Sarah Keep; Phoebe Stevenson-Leggett; Giulia Dowgier; Katalin Foldes; Isobel Webb; Albert Fones; Kieran Littolff; Holly Everest; Paul Britton; Erica Bickerton
Journal:  J Virol       Date:  2022-08-16       Impact factor: 6.549

7.  Viral pneumonia in children.

Authors:  Kelly J Henrickson
Journal:  Semin Pediatr Infect Dis       Date:  2006-06-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.